TITLE

Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up

AUTHOR(S)
Yuksel, B; Greenough, A
PUB. DATE
November 1992
SOURCE
Thorax;Nov1992, Vol. 47 Issue 11, p910
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66092919

 

Related Articles

  • A Randomized Trial of Inhaled Versus Intravenous Steroids in Ventilator-Dependent Preterm Infants. Suchomski, Sandra J; Cummings, James J // Journal of Perinatology;Apr2002, Vol. 22 Issue 3, p196 

    OBJECTIVE: Intravenous steroids improve the respiratory course in ventilator - dependent preterm infants but have adverse effects. We hypothesized that inhaled steroids would be as effective, but with less systemic effects. STUDY DESIGN: We conducted a randomized, prospective trial comparing...

  • A three year follow up of preterm infants after moderately early treatment with dexamethasone. Romagnoli, C.; Zecca, E.; Luciano, R.; Torrioli, G.; Tortorolo, G. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2002, Vol. 87 Issue 1, pF55 

    Objective: To assess the effect of moderately early postnatal dexamethasone treatment on growth and neurodevelopmental outcome in preterm infants. Methods: Thirty preterm infants enrolled in a randomised clinical trial to investigate the effectiveness of moderately early dexamethasone...

  • Inhaled NO for Preterm Infants – Getting to Yes? Stark, Ann R. // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p404 

    The author reflects on the advantages of inhaled nitric oxide (NO) among preterm infants. Lung inflammation linked with mechanical injury may contribute to bronchopulmonary dysplasia among preterm infants. Reports showed that inhaled NO improved oxygenation in preterm infants with severe...

  • Respiratory syncytial virus prophylaxis reduces chronic respiratory morbidity in prematurely born infants. Greenough, Anne // Evidence Based Medicine;Apr2014, Vol. 19 Issue 2, p65 

    The author discusses a study on respiratory syncytial virus (RSV) and lower respiratory tract infections (LRTIs) with chronic respiratory morbidity (CRM) in preterm infants. Topics include the use of double blind and randomised controlled trials in 429 infants born between 33 and 35 weeks of...

  • Postnatal Corticosteroids for Preterm Infants – Do What We Say, Not What We Do. Jobe, Alan H. // New England Journal of Medicine;3/25/2004, Vol. 350 Issue 13, p1349 

    This article reports on the use of postnatal corticosteroids for preterm infants. Physicians caring for pregnant women and their preterm infants have used corticosteroids since 1972, because prenatal betamethasone decreased the incidence of the respiratory distress syndrome and increased the...

  • Respiratory complications of preterm birth. Fraser, Jenny; Walls, Moira; McGuire, William // BMJ: British Medical Journal (International Edition);10/23/2004, Vol. 329 Issue 7472, p962 

    Focuses on respiratory distress syndrome of prematurity which is a major cause of morbidity and mortality in preterm infants. How respiratory distress syndrome is caused by deficiency of pulmonary surfactant; Benefits of giving expectant mothers, at risk for preterm delivery, corticosteroids...

  • Editorial. Greenough, Anne // Current Pediatric Reviews;2008, Vol. 4 Issue 1, p1 

    Bronchopulmonary dysplasia (BPD) is a common adverse outcome of premature birth, affecting approximately 40% of those born prior to 29 weeks of gestation. It has long term adverse consequences including recurrent respiratory symptoms requiring treatment and lung function abnormalities at school...

  • Management of Bronchopulmonary Dysplasia in Infants: Guidelines for Corticosteroid Use. Grier, David G.; Halliday, Henry L. // Drugs;2005, Vol. 65 Issue 1, p15 

    Bronchopulmonary dysplasia (BPD) is a common cause of morbidity and mortality in preterm neonates and at present its management is unclear. Over the past three decades there has been a growing use of corticosteroids in the postnatal period; first for the treatment and then, more recently, for...

  • Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia? Eichenwald, Eric C.; Stark, Ann R. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2007, Vol. 92 Issue 5, pF334 

    The article cites a study concerning the effect of postnatal steroids in preterm infants. Several clinical trials confirmed that prenatal glucocorticoid treatment of women in preterm delivery increases survival and reduces the risk of respiratory distress syndrome including intraventricular...

  • Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial. Dodd, Jodie M.; Crowther, Caroline A.; McPhee, Andrew J.; Flenady, Vicki; Robinson, Jeffrey S. // BMC Pregnancy & Childbirth;2009, Vol. 9, Special section p1 

    Background: Neonatal respiratory distress syndrome, as a consequence of preterm birth, is a major cause of early mortality and morbidity during infancy and childhood. Survivors of preterm birth continue to remain at considerable risk of both chronic lung disease and long-term neurological...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics